MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 05-16-2026
Apollo Endosurgery Total Current Liabilities 2011-2026 | APEN
Annual Total Current Liabilities Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39.5 M | 14.5 M | 11.7 M | 52.8 M | 24.4 M | 25.8 M | 20.3 M | 21.3 M | 4.26 M | 3.53 M | 8.63 M | 10.1 M | 9.42 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 52.8 M | 3.53 M | 18.9 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M |  USA |
 |
EDAP TMS S.A.
EDAP
|
37.8 M | - | - | $ 162 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
45.8 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
10.8 M | $ 13.42 | -0.15 % | $ 380 M | USA |
 |
Alphatec Holdings
ATEC
|
219 M | $ 8.32 | 0.42 % | $ 1.25 B | USA |
 |
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
42.8 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | USA |
 |
IRIDEX Corporation
IRIX
|
13.2 M | $ 1.13 | 0.89 % | $ 19.1 M | USA |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.02 M | $ 1.77 | 14.93 % | $ 39 M | USA |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
9.71 M | $ 0.43 | 7.13 % | $ 26.8 M | USA |
 |
LivaNova PLC
LIVN
|
808 M | $ 79.66 | 0.34 % | $ 4.35 B |  Britain |
 |
Pulmonx Corporation
LUNG
|
20.1 M | $ 1.33 | -2.92 % | $ 54.1 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 17.74 | -0.45 % | $ 416 M | USA |
 |
Delcath Systems
DCTH
|
11 M | $ 11.9 | 1.54 % | $ 426 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Orthofix Medical
OFIX
|
170 M | $ 9.33 | 0.19 % | $ 369 M |  Curacao |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
LENSAR
LNSR
|
40.6 M | $ 5.78 | -0.69 % | $ 69.1 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
10.5 M | $ 38.5 | 2.31 % | $ 325 M | USA |
 |
MiMedx Group
MDXG
|
64.3 M | $ 3.7 | 2.64 % | $ 547 M | USA |
 |
Profound Medical Corp.
PROF
|
6.08 M | $ 6.98 | 5.36 % | $ 211 M |  Canada |
 |
Butterfly Network
BFLY
|
65.1 M | $ 5.6 | 1.08 % | $ 1.38 B | USA |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
6.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Myomo
MYO
|
8.35 M | $ 1.34 | 16.09 % | $ 56.1 M | USA |
 |
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
498 M | $ 77.27 | -3.88 % | $ 10.4 B | USA |
 |
Insulet Corporation
PODD
|
680 M | $ 149.63 | -0.05 % | $ 10.5 B | USA |
 |
CONMED Corporation
CNMD
|
315 M | $ 34.54 | -0.66 % | $ 1.07 B | USA |
 |
Inspire Medical Systems
INSP
|
96.1 M | $ 41.16 | -3.61 % | $ 1.21 B | USA |
 |
Integer Holdings Corporation
ITGR
|
232 M | $ 90.81 | -0.19 % | $ 3.15 B | USA |
 |
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.81 B | $ 84.95 | -0.19 % | $ 49.7 B | USA |
 |
TransMedics Group
TMDX
|
89.3 M | $ 75.61 | 3.7 % | $ 2.57 B | USA |